Emiltatug ledadotin (Emi-Le)

Name: Emiltatug ledadotin (Emi-Le) in Adenoid cystic carcinoma with solid histology or high-grade transformation: Disease description
Published: 2026-09-17T22:01:26-04:00

Adenoid cystic carcinoma with solid histology or high-grade transformation

Also known as XMT-1660

Manufacturer: Servier
Regulatory submission: Not announced
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy

Disease description

102 evidence topics · 48 sources

Definition and etiology11 evidence topics · 20 sources
Epidemiology12 evidence topics · 16 sources
Natural history, survival, and mortality17 evidence topics · 23 sources
Pathophysiology11 evidence topics · 11 sources
Diagnosis11 evidence topics · 15 sources
Clinical presentation - signs and symptoms11 evidence topics · 12 sources
Long-term morbidity6 evidence topics · 6 sources
Burden of Adenoid cystic carcinoma with solid histology or high-grade transformation23 evidence topics · 15 sources